EBITDA

The Oncology Institute promotes new CIO and CPO, signaling a strategic push into AI-driven care and robust talent management to dominate the market.

With $82M in funding and novel gene insertion technology, Averna Therapeutics is poised to make waves at the pivotal J.P. Morgan Healthcare Conference.

With record revenue and a bold AI strategy, Opera heads to a key investor conference. Can its 'agentic' browsers redefine the web and win market share?

Biocytogen and Acepodia are expanding their partnership to create next-gen ADCs with two targets and two warheads, aiming to defeat drug-resistant cancers.

Facing complex 2025 tax changes? H&R Block is offering new DIY clients a free professional review, blending digital convenience with expert assurance.

An expanded partnership aims to create next-gen cancer therapies by combining bispecific antibodies with two distinct drugs to overcome tumor resistance.

Major insurers now cover advanced AI plaque analysis, paving the way for personalized heart attack prevention and a new standard of cardiovascular care.

The biotech firm now expects Phase 2 results in Q3 2026, accelerating hope for new CNS treatments and signaling strong operational momentum to investors.

Predis.ai's new AI promises to slash video ad costs and production time, empowering small businesses and challenging traditional marketing workflows.

A massive 20-year pact between Meta and Vistra will revive three nuclear plants, adding new carbon-free power to fuel the AI and data center revolution.

Kezar Life Sciences faces a critical FDA meeting for its novel liver disease drug, a decision that could bring hope to patients and define the company's future.

Pandora's 2025 growth slows amid weak consumer sentiment, but a new CEO plans a strategic reset to combat rising costs and boost brand desirability.

Amid a major corporate restructure, Atos partners with the World DanceSport Federation, betting on tech to transform the ballroom and secure its market lead.

At AIMExpo 2026, ASMAX unveiled a rider-centric IoT ecosystem, aiming to redefine group communication and safety with advanced mesh and AI technology.

A 2.9 MEUR deal for GomSpace to design lunar spacecraft for a major North American firm signals a new era for small satellites in deep space exploration.

As 2026 begins, the crypto market sees a split personality: a wild memecoin surge alongside a steady, tech-driven recovery in the AI sector.

Global Capability Centers are shedding their cost-center image, embracing AI-first models and expanding into new Indian cities to become strategic innovators.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

The smartphone giant joins the VVC Advance patent pool, a key move poised to speed up the adoption of next-gen video codecs for consumers worldwide.

Ventyx Biosciences is under investigation for misleading investors after a trial delay caused a 15% stock drop, even as a pharma giant moves to acquire it.